Literature DB >> 27272030

Low Relative Lean Mass is Associated with Increased Likelihood of Abdominal Aortic Calcification in Community-Dwelling Older Australians.

Alexander J Rodríguez1, David Scott2,3,4, Belal Khan3,5, Nayab Khan6, Allison Hodge7, Dallas R English7, Graham G Giles7, Peter R Ebeling2,3,4.   

Abstract

Age-related loss of skeletal muscle is associated with increased risk of functional limitation and cardiovascular (CV) mortality. In the elderly abdominal aortic calcification (AAC) can increase CV risk by altering aortic properties which may raise blood pressure and increase cardiac workload. This study investigated the association between low muscle mass and AAC in community-dwelling older Australians. Data for this cross-sectional analysis were drawn from a 2010 sub-study of the Melbourne Collaborative Cohort Study in the setting of community-dwelling older adults. Three hundred and twenty-seven participants [mean age = 71 ± 6 years; mean BMI = 28 ± 5 kg/m(2); females n = 199 (62 %)] had body composition determined by dual-energy x-ray absorptiometry (DXA) and AAC determined by radiography. Participants were stratified into tertiles of sex-specific BMI-normalised appendicular lean mass (ALM). Those in the lowest tertile were considered to have low relative muscle mass. Aortic calcification score (ACS) was determined visually as the extent of calcification on the aortic walls between L1 and L4 vertebrae (range: 0-24). Severe AAC was defined as ACS ≥ 6. Prevalence of any AAC was highest in participants with low relative muscle mass (74 %) compared to the middle (65 %) and upper (53 %) tertiles (p trend = 0.006). The lower ALM/BMI tertile had increased odds (Odds ratio = 2.3; 95 % confidence interval: 1.1-4.6; p = 0.021) of having any AAC; and having more severe AAC (2.2; 1.2-4.0; p = 0.009) independent of CV risk factors, serum calcium and physical activity. AAC is more prevalent and severe in community-dwelling older adults with low relative muscle mass. Maintaining muscle mass could form part of a broader primary prevention strategy in reducing AAC.

Entities:  

Keywords:  Ageing; Aortic calcification; Cardiovascular disease; Muscle; Sarcopenia

Mesh:

Year:  2016        PMID: 27272030     DOI: 10.1007/s00223-016-0157-z

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

Review 1.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

Review 2.  Vascular dysfunction as a potential culprit of sarcopenia.

Authors:  Yun Kyung Jeon; Myung Jun Shin; Sunil Kumar Saini; Carlo Custodero; Monica Aggarwal; Stephen D Anton; Christiaan Leeuwenburgh; Robert T Mankowski
Journal:  Exp Gerontol       Date:  2020-12-26       Impact factor: 4.032

3.  Association of Postoperative Neutrophil Lymphocyte Ratio (NLR) and Monocyte Lymphocyte Ratio (MLR) with the Presence of Osteoporosis in Japanese Patients after Hip Fracture Surgery: A Retrospective Cohort Study.

Authors:  Hirofumi Bekki; Takeshi Arizono; Daiki Hama; Akihiko Inokuchi; Takahiro Hamada; Ryuta Imamura
Journal:  J Osteoporos       Date:  2021-09-15

4.  Why Aboriginal and Torres Strait Islander Australians fall and fracture: the codesigned Study of Indigenous Muscle and Bone Ageing (SIMBA) protocol.

Authors:  Ayse Zengin; Cat Shore-Lorenti; Marc Sim; Louise Maple-Brown; Sharon Lee Brennan-Olsen; Joshua R Lewis; Jennifer Ockwell; Troy Walker; David Scott; Peter Ebeling
Journal:  BMJ Open       Date:  2022-04-04       Impact factor: 2.692

Review 5.  Ascending Aortic Calcification as a Potential Predictor for Low Bone Mineral Density: A Pilot Study.

Authors:  Hirofumi Bekki; Takeshi Arizono; Yuki Suzuki; Akihiko Inokuchi; Takahiro Hamada; Ryuta Imamura; Ryunosuke Oyama; Yuki Hyodo; Eiji Kinoshita; Takumi Kita
Journal:  J Osteoporos       Date:  2021-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.